35292770|t|Trilobatin rescues cognitive impairment of Alzheimer's disease by targeting HMGB1 through mediating SIRT3/SOD2 signaling pathway.
35292770|a|Alzheimer's disease (AD) is a progressive neurodegenerative disorder with cognitive impairment that currently is uncurable. Previous study shows that trilobatin (TLB), a naturally occurring food additive, exerts neuroprotective effect in experimental models of AD. In the present study we investigated the molecular mechanisms underlying the beneficial effect of TLB on experimental models of AD in vivo and in vitro. APP/PS1 transgenic mice were administered TLB (4, 8 mg  kg-1  d-1, i.g.) for 3 months; rats were subjected to ICV injection of Abeta25-35, followed by administration of TLB (2.5, 5, 10 mg  kg-1  d-1, i.g.) for 14 days. We showed that TLB administration significantly and dose-dependently ameliorated the cognitive deficits in the two AD animal models, assessed in open field test, novel object recognition test, Y-maze test and Morris water maze test. Furthermore, TLB administration dose-dependently inhibited microglia and astrocyte activation in the hippocampus of APP/PS1 transgenic mice accompanied by decreased expression of high-mobility group box 1 (HMGB1), TLR4 and NF-kappaB. In Abeta25-25-treated BV2 cells, TLB (12.5-50 muM) concentration-dependently increased the cell viability through inhibiting HMGB1/TLR4/NF-kappaB signaling pathway. HMGB1 overexpression abrogated the beneficial effects of TLB on BV2 cells after Abeta25-35 insults. Molecular docking and surface plasmon resonance assay revealed that TLB directly bound to HMGB1 with a KD value of 8.541x10-4 M. Furthermore, we demonstrated that TLB inhibited Abeta25-35-induced acetylation of HMGB1 through activating SIRT3/SOD2 signaling pathway, thereby restoring redox homeostasis and suppressing neuroinflammation. These results, for the first time, unravel a new property of TLB: rescuing cognitive impairment of AD via targeting HMGB1 and activating SIRT3/SOD2 signaling pathway.
35292770	0	10	Trilobatin	Chemical	MESH:C000598619
35292770	19	39	cognitive impairment	Disease	MESH:D003072
35292770	43	62	Alzheimer's disease	Disease	MESH:D000544
35292770	76	81	HMGB1	Gene	15289
35292770	100	105	SIRT3	Gene	64384
35292770	106	110	SOD2	Gene	20656
35292770	130	149	Alzheimer's disease	Disease	MESH:D000544
35292770	151	153	AD	Disease	MESH:D000544
35292770	172	198	neurodegenerative disorder	Disease	MESH:D019636
35292770	204	224	cognitive impairment	Disease	MESH:D003072
35292770	280	290	trilobatin	Chemical	MESH:C000598619
35292770	292	295	TLB	Chemical	MESH:C000598619
35292770	391	393	AD	Disease	MESH:D000544
35292770	493	496	TLB	Chemical	MESH:C000598619
35292770	523	525	AD	Disease	MESH:D000544
35292770	552	555	PS1	Gene	19164
35292770	567	571	mice	Species	10090
35292770	590	593	TLB	Chemical	MESH:C000598619
35292770	635	639	rats	Species	10116
35292770	717	720	TLB	Chemical	MESH:C000598619
35292770	782	785	TLB	Chemical	MESH:C000598619
35292770	852	870	cognitive deficits	Disease	MESH:D003072
35292770	882	884	AD	Disease	MESH:D000544
35292770	1013	1016	TLB	Chemical	MESH:C000598619
35292770	1120	1123	PS1	Gene	19164
35292770	1135	1139	mice	Species	10090
35292770	1179	1204	high-mobility group box 1	Gene	15289
35292770	1206	1211	HMGB1	Gene	15289
35292770	1214	1218	TLR4	Gene	21898
35292770	1223	1233	NF-kappaB.	Gene	18033
35292770	1237	1247	Abeta25-25	Chemical	-
35292770	1256	1259	BV2	CellLine	CVCL:0182
35292770	1267	1270	TLB	Chemical	MESH:C000598619
35292770	1359	1364	HMGB1	Gene	15289
35292770	1365	1369	TLR4	Gene	21898
35292770	1370	1379	NF-kappaB	Gene	18033
35292770	1399	1404	HMGB1	Gene	15289
35292770	1456	1459	TLB	Chemical	MESH:C000598619
35292770	1463	1466	BV2	CellLine	CVCL:0182
35292770	1567	1570	TLB	Chemical	MESH:C000598619
35292770	1589	1594	HMGB1	Gene	15289
35292770	1662	1665	TLB	Chemical	MESH:C000598619
35292770	1710	1715	HMGB1	Gene	15289
35292770	1735	1740	SIRT3	Gene	64384
35292770	1741	1745	SOD2	Gene	20656
35292770	1817	1834	neuroinflammation	Disease	MESH:D000090862
35292770	1897	1900	TLB	Chemical	MESH:C000598619
35292770	1911	1931	cognitive impairment	Disease	MESH:D003072
35292770	1935	1937	AD	Disease	MESH:D000544
35292770	1952	1957	HMGB1	Gene	15289
35292770	1973	1978	SIRT3	Gene	64384
35292770	1979	1983	SOD2	Gene	20656
35292770	Association	MESH:D003072	64384
35292770	Association	MESH:D003072	20656
35292770	Negative_Correlation	MESH:C000598619	18033
35292770	Negative_Correlation	MESH:C000598619	MESH:D003072
35292770	Association	MESH:C000598619	20656
35292770	Association	15289	64384
35292770	Negative_Correlation	MESH:C000598619	21898
35292770	Association	15289	20656
35292770	Negative_Correlation	MESH:C000598619	15289
35292770	Positive_Correlation	MESH:C000598619	64384
35292770	Negative_Correlation	MESH:C000598619	MESH:D000544

